Denmark-based pharmaceutical company specializing in allergy immunotherapy products; one of the world's largest makers of allergy immunotherapy, with operations across 46 countries. Listed on Nasdaq Copenhagen (ALK B), with the Lundbeck Foundation as strategic shareholder.